Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Direct measurement of Ca2+ concentration in the SR of living cardiac myocytes.
Kasai H, Yao A, Oyama T, Hasegawa H, Akazawa H, Toko H, Nagai T, Kinugawa K, Kohmoto O, Maruyama K, Takahashi T, Nagai R, Miyawaki A, Komuro I. Kasai H, et al. Among authors: komuro i. Biochem Biophys Res Commun. 2004 Feb 20;314(4):1014-20. doi: 10.1016/j.bbrc.2003.12.189. Biochem Biophys Res Commun. 2004. PMID: 14751234
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.
Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Abe K, Suzuki N, Eto T, Higaki J, Ito S, Kamiya A, Kikuchi K, Suzuki H, Tei C, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Matsuzaki M, et al. J Hypertens. 2011 Aug;29(8):1649-59. doi: 10.1097/HJH.0b013e328348345d. J Hypertens. 2011. PMID: 21610513 Clinical Trial.
Trend of clinical outcome and surrogate markers during titration of β-blocker in heart failure patients with reduced ejection fraction: relevance of achieved heart rate and β-blocker dose.
Kato N, Kinugawa K, Imamura T, Muraoka H, Minatsuki S, Inaba T, Maki H, Shiga T, Hatano M, Yao A, Komuro I, Nagai R. Kato N, et al. Among authors: komuro i. Circ J. 2013;77(4):1001-8. doi: 10.1253/circj.cj-12-1241. Epub 2012 Dec 19. Circ J. 2013. PMID: 23258250 Free article. Clinical Trial.
Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction.
Matsumoto S, Nakatani D, Sakata Y, Suna S, Shimizu M, Usami M, Hara M, Sumitsuji S, Nanto S, Sasaki T, Hamasaki T, Sato H, Hori M, Komuro I; Osaka Acute Coronary Insufficiency Study (OACIS) Group. Matsumoto S, et al. Among authors: komuro i. Circ J. 2013;77(4):1026-32. doi: 10.1253/circj.cj-12-0999. Epub 2012 Dec 29. Circ J. 2013. PMID: 23291993 Free article. Clinical Trial.
Diagnostic implication of change in b-type natriuretic peptide (BNP) for prediction of subsequent target lesion revascularization following silorimus-eluting stent deployment.
Hasumi E, Iwata H, Kohro T, Manabe I, Kinugawa K, Morisaki N, Ando J, Sawaki D, Takahashi M, Fujita H, Yamashita H, Ako J, Hirata Y, Komuro I, Nagai R. Hasumi E, et al. Among authors: komuro i. Int J Cardiol. 2013 Sep 30;168(2):1429-34. doi: 10.1016/j.ijcard.2012.12.046. Epub 2013 Jan 7. Int J Cardiol. 2013. PMID: 23302112
1,474 results